News
STENTIT raises €12,5M EIC Accelerator
Venture Challenge alumnus Stentit has successfully raised €12.5M in funding from the EIC Accelerator.
The consortium led by ParaMedir awarded around €600,00.00 EFRO subsidy by SNN to develop solutions to improve outcome of acute heart failure patients.
Groningen – ParaMedir, an innovative medical technology company based in the Northern Netherlands, is proud to announce the significant EFRO subsidy of about €600,000.00 awarded by SNN (Samenwerkingsverband Noord-Nederland).
SeraNovo announces the closing of a multicompound deal with AstraZeneca
Leiden - Venture Challenge alumnus and winner SeraNovo announces a collaboration with AstraZeneca on multiple research projects. Source: Seranovo
Protinhi Therapeutics is awarded €7.5 Million by the EIC Accelerator program
• The funding will be dedicated to developing our broad-spectrum pan-flavi antiviral drug PTL244 to clinical phase II stage for the most common flavivirus: dengue. • Dengue is endemic in more than 100 countries (a.o.
These are the Venture Challenge Spring 2023 teams!
Six teams will start the Venture Challenge. Between 10 May and 29 June these starting lifesciences entrepreneurs will learn everything there is to know about setting up and pitching a businessplan.
Venture Challenge Fall 2023 open for applications!
Are you a researcher in the life sciences and are you looking to turn your research into a viable product or service that helps patients, physicians or other researchers?
Sirius Medical Announces Major Funding Round To Further Accelerate Sales Growth and New Product Development
Eindhoven, Netherlands – 21 March 2023 – Sirius Medical, the leader in surgical marker navigation, today announced the successful closing of a Series B Round 12 M€.
Prolira Announces FDA Clearance of the DeltaScan®
Prolira Announces FDA Clearance of the DeltaScan® Brain State Monitor for Detecting Acute Encephalopathy (Acute Brain Failure), a Condition Affecting Millions of Hospitalized Patients 60 and Old
Oxford Nanopore Technologies and Cyclomics begin developer testing on non-invasive method for accurate and fast detection of molecules associated with cancer
Research collaboration has resulted in new ‘liquid biopsy’ research workflow using nanopore sequencing to detect molecules that are associated with cancer, circulating in blood
Cyclomics announces completion of seed financing round
Venture Challenge alumnus Cyclomics has completed a financing round driven by a group of private investors too accelerate the development of innovate technologies in the field of cancer genetic testing.